Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Consolidated Net IncomeEBITEBITDAEBTEPS (Basic)EPS (Weighted Average and Diluted)Income from Continuing OperationsIncome towards Parent CompanyInterest & Investment IncomeInterest ExpensesNet Income towards Common StockholdersNon Operating IncomeOperating ExpensesOperating IncomeOther Non Operating IncomeOther Operating ExpensesProfit After TaxResearch & DevelopmentRevenueSelling, General & AdministrativeShares OutstandingShares Outstanding (Weighted Average)Tax ProvisionsTax Rate
Others
Ratios

Ironwood Pharmaceuticals (IRWD) Gross Profit (2017 - 2020)

Ironwood Pharmaceuticals (IRWD) has disclosed Gross Profit for 7 consecutive years, with $115.8 million as the latest value for Q4 2020.

  • Quarterly Gross Profit changed 0.43% to $115.8 million in Q4 2020 from the year-ago period, while the trailing twelve-month figure was $386.4 million through Dec 2020, up 26.36% year-over-year, with the annual reading at $386.4 million for FY2020, 4.49% down from the prior year.
  • Gross Profit hit $115.8 million in Q4 2020 for Ironwood Pharmaceuticals, up from $103.5 million in the prior quarter.
  • In the past five years, Gross Profit ranged from a high of $115.8 million in Q4 2020 to a low of -$21.3 million in Q4 2018.
  • Historically, Gross Profit has averaged $69.9 million across 4 years, with a median of $77.4 million in 2018.
  • Biggest five-year swings in Gross Profit: tumbled 124.95% in 2018 and later skyrocketed 642.2% in 2019.
  • Year by year, Gross Profit stood at $85.2 million in 2017, then crashed by 124.95% to -$21.3 million in 2018, then surged by 642.2% to $115.3 million in 2019, then grew by 0.43% to $115.8 million in 2020.
  • Business Quant data shows Gross Profit for IRWD at $115.8 million in Q4 2020, $103.5 million in Q3 2020, and $89.4 million in Q2 2020.